Clinical Trial Update: Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating terlipressin for hepatorenal syndrome type 1 has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatorenal Syndrome

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: Mallinckrodt | Conditions: Hepatorenal Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2022-08-18